Patents Assigned to Krouzon Pharmaccuticals, Inc.
  • Octahydrocyclopenta[c]pyrrole allosteric inhibitors of SHP2
    Patent number: 10435389
    Abstract: The present invention relates to compounds capable of inhibiting the activity of SHP2. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds, and methods of using such compounds and compositions in the management of diseases or disorders associated with the aberrant activity of SHP2.
    Type: Grant
    Filed: September 11, 2018
    Date of Patent: October 8, 2019
    Assignee: Krouzon Pharmaccuticals, Inc.
    Inventors: Robert Volkmann, Anthony Marfat, Frederick Nelson, Panayiotis Zagouras